Increasing Objective Cardiometabolic Burden Associated With Attenuations in the P3b Event-Related Potential Component

Hannah A D Keage1, Daniel Feuerriegel2, Danielle Greaves1

  • 1Cognitive Ageing and Impairment Neurosciences Laboratory, Justice and Society, University of South Australia, Adelaide, SA, Australia.

Frontiers in Neurology
|September 9, 2020
PubMed

Insights

Cardiometabolic health impacts brain activity in older adults. Increased cardiometabolic burden is linked to reduced P3b brainwave amplitude during working memory tasks, suggesting potential for event-related potentials in monitoring cognitive health.

Area of Science:

  • Neuroscience
  • Gerontology
  • Cardiology

Background:

  • Cardiometabolic diseases are linked to cognitive decline and brain structure changes in older adults.
  • Functional brain changes associated with cardiometabolic health in late-life remain unclear.
  • Event-related potentials (ERPs) offer a window into neural processing during cognitive tasks.

Purpose of the Study:

  • To characterize functional brain changes related to cardiometabolic health in aging using ERPs.
  • To investigate the association between cardiometabolic burden and neural activity during a working memory task.
  • To explore the utility of ERPs for monitoring interventions targeting cardiometabolic factors.

Main Methods:

  • Recruited 85 adults (50-80 years) with varied cognitive and cardiometabolic health.
  • Recorded event-related potentials (ERPs) during a 0, 1, and 2-back working memory task.
  • Calculated a summative cardiometabolic burden score based on blood glucose, obesity, cholesterol, and hypertension cut-offs.

Main Results:

  • No significant association found between cardiometabolic burden and P1/N1 visual component amplitudes.
  • A significant decrease in P3b component amplitude was observed with increasing cardiometabolic burden.
  • Findings demonstrate a link between cardiometabolic factors and brain activity (ERPs) in older adults.

Conclusions:

  • Cardiometabolic factors associated with cognitive impairment in late-life correlate with altered brain activity (ERPs).
  • ERPs may serve as sensitive markers for change in aging and lifestyle interventions targeting cardiometabolic health.
  • Future ERP studies should consider participants' cardiometabolic health status.

Related Concept Videos

Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
120
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism

Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
115
Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
131
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption01:22

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption

As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
131
Aging01:26

Aging

Aging is a complex biological phenomenon influenced by various processes that affect cellular and systemic functions. Several prominent theories attempt to explain its mechanisms, highlighting cellular limitations, oxidative damage, and hormonal changes as central factors in aging.
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
482
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
236